HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markus Exner Selected Research

Pathologic Constriction (Stenosis)

11/2004High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting.
6/2004Excessive carotid in-stent neointimal formation predicts late cardiovascular events.
5/2003Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis.
8/2002Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Markus Exner Research Topics

Disease

19Atherosclerosis
10/2014 - 07/2002
17Inflammation (Inflammations)
07/2011 - 06/2002
15Myocardial Infarction
07/2011 - 05/2002
11Peripheral Arterial Disease
05/2012 - 02/2002
10Stroke (Strokes)
07/2011 - 11/2003
8Carotid Artery Diseases
08/2015 - 05/2005
4Abdominal Aortic Aneurysm
05/2008 - 04/2002
4Cardiovascular Diseases (Cardiovascular Disease)
06/2007 - 11/2003
4Pathologic Constriction (Stenosis)
11/2004 - 08/2002
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2004 - 12/2002
3Atherosclerotic Plaque (Atheroma)
08/2015 - 11/2003
3Carotid Stenosis (Carotid Artery Stenosis)
04/2007 - 06/2006
3Type 2 Diabetes Mellitus (MODY)
10/2005 - 12/2002
3Vascular Diseases (Vascular Disease)
01/2004 - 01/2003
2Chronic Renal Insufficiency
10/2014 - 11/2013
2Proteinuria
07/2006 - 06/2002
2Ischemia
10/2005 - 02/2004
2Ischemic Stroke
07/2005 - 01/2004
2Diabetes Mellitus
11/2004 - 01/2003
2Hypertension (High Blood Pressure)
08/2004 - 03/2004
1Uremia
11/2012
1Glomerulonephritis
10/2008
1Weight Loss (Weight Reduction)
11/2007
1Anorexia
11/2007
1Body Weight (Weight, Body)
11/2007
1Septic Shock (Toxic Shock Syndrome)
11/2007
1Lung Injury
11/2007
1Endotoxemia
11/2007
1Intermittent Claudication
02/2007
1Melanoma (Melanoma, Malignant)
09/2006
1Tooth Loss
09/2006
1False Aneurysm (Pseudoaneurysm)
08/2006
1Sepsis (Septicemia)
05/2006
1Aortic Dissection
05/2006

Drug/Important Bio-Agent (IBA)

8oxidized low density lipoproteinIBA
10/2014 - 11/2003
8C-Reactive ProteinIBA
04/2007 - 11/2003
7omega-Chloroacetophenone (Mace)IBA
04/2011 - 11/2003
6Heme Oxygenase-1IBA
09/2006 - 04/2002
6Fibrinogen (Factor I)FDA Link
11/2005 - 06/2002
5AntioxidantsIBA
11/2013 - 11/2003
5Serum Amyloid A Protein (Serum Amyloid A)IBA
11/2005 - 06/2002
3Peroxidase (Myeloperoxidase)IBA
05/2012 - 06/2006
3BilirubinIBA
11/2007 - 07/2003
3LipidsIBA
06/2007 - 01/2004
3Indicators and Reagents (Reagents)IBA
07/2005 - 05/2002
2E-SelectinIBA
08/2015 - 01/2003
2Proteins (Proteins, Gene)FDA Link
11/2012 - 11/2003
2AntigensIBA
10/2008 - 02/2007
2IsoenzymesIBA
10/2005 - 02/2004
2CreatinineIBA
08/2004 - 02/2004
2Serum AlbuminIBA
05/2004 - 03/2004
2AlbuminsIBA
05/2004 - 03/2004
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
09/2003 - 12/2002
2EnzymesIBA
01/2003 - 12/2002
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2015
1SelectinsIBA
08/2015
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2015
1Uremic ToxinsIBA
10/2014
1CyanatesIBA
11/2013
1Cysteine (L-Cysteine)FDA Link
11/2013
1Threonine (L-Threonine)FDA Link
11/2012
1Oxidants (Oxidizing Agents)IBA
11/2012
1Amino AcidsFDA Link
11/2012
1LDL Lipoproteins (beta Lipoproteins)IBA
05/2012
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
07/2011
1Sulfhydryl Compounds (Thiols)IBA
04/2011
1Cystatin CIBA
04/2010
1AutoantibodiesIBA
10/2008
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2008
1UDP Xylose-Protein XylosyltransferaseIBA
05/2008
1Biliverdine (Biliverdin)IBA
11/2007
1ChloridesIBA
07/2007
1Hypochlorous Acid (Hypochlorite)IBA
07/2007
1LigandsIBA
06/2007
1Fibric Acids (Fibrates)IBA
06/2007
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2007
1Insulin (Novolin)FDA Link
06/2007
1ThiazolidinedionesIBA
06/2007
1hypericinIBA
02/2007
1GenisteinIBA
01/2007
1oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA
01/2007
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2007
1Estrogen ReceptorsIBA
01/2007
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
11/2006
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
07/2006
1Tacrolimus (Prograf)FDA LinkGeneric
07/2006
1HDL CholesterolIBA
06/2006
1LDL CholesterolIBA
06/2006
1Antithrombin IIIIBA
05/2006

Therapy/Procedure

8Percutaneous Coronary Intervention
07/2011 - 11/2003
8Stents
11/2004 - 02/2002
6Therapeutics
08/2015 - 01/2004
6Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2007 - 11/2003
2Carotid Endarterectomy
01/2004 - 05/2003
1Vascular Surgical Procedures
11/2007
1Surgical Amputation (Amputations)
11/2007
1Oral Hygiene (Dental Hygiene)
09/2006
1Endovascular Procedures
08/2006
1Punctures
08/2006